Pharmacokinetics, Efficacy, and Safety of a SARS-CoV-2 Antibody Treatment in Pediatric Participants: An Open-Label Addendum of a Placebo-Controlled, Randomized Phase 2/3 Trial
SARS-CoV-2 抗体治疗在儿科受试者中的药代动力学、疗效和安全性:一项安慰剂对照、随机 2/3 期试验的开放标签补充研究
期刊:Infectious Diseases and Therapy
影响因子:5.3
doi:10.1007/s40121-023-00832-y
Upadhyaya, Himanshu P; Chien, Jenny Y; Long, Amanda J; Bohm, Martin S; Kallewaard, Nicole L; Macpherson, Lisa F; Patel, Dipak R; Hufford, Matthew M; Krull, Constance J; Ang, Jocelyn Y; Chen, Peter; Muller, William J; Potts, Jeffrey A; Quinn, Timothy; Williams, Mark